Cargando…
Pandemic Best Regulatory Practices: An Urgent Need in the COVID‐19 Pandemic
As large numbers of candidate drugs and vaccines for potential use in the coronavirus disease 2019 (COVID‐19) pandemic are being investigated, medicine regulators globally must now make urgent, informed, contextually risk‐1based decisions regarding clinical trials and marketing authorizations. They...
Autores principales: | Lumpkin, Murray M., Lim, John C. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300901/ https://www.ncbi.nlm.nih.gov/pubmed/32498131 http://dx.doi.org/10.1002/cpt.1932 |
Ejemplares similares
-
Navigating facilitated regulatory pathways during a disease X pandemic
por: Simpson, Shmona, et al.
Publicado: (2020) -
The COVID‐19 crisis as an opportunity to strengthen global regulatory coordination for sustained enhanced access to diagnostics and therapeutics
por: Soumyanarayanan, Uttara, et al.
Publicado: (2021) -
Child food insecurity in the wake of the COVID-19 pandemic: urgent need for policy evaluation and reform in Israel’s school feeding programs
por: Azarieva, Janetta, et al.
Publicado: (2022) -
Lessons learned from urgent computing in Europe: Tackling the COVID-19 pandemic
por: López, Núria, et al.
Publicado: (2021) -
Approaches and Best Practices for Managing Cancer Pain within the Constraints of the COVID-19 Pandemic in India
por: Damani, Anuja, et al.
Publicado: (2020)